Inflammatory Arthritis Post Covid-19 Infection.

Deeb, M; Moloney, P B; McCarthy, G; Stack, J; Lynch, T; Llamas Osorio, Y

Deeb, M; Moloney, P B; McCarthy, G; Stack, J; Lynch, T; Llamas Osorio, Y.

Afiliação

Deeb M; Department of Neurology, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Moloney PB; Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
McCarthy G; Department of Neurology, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Stack J; Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
Lynch T; Department of Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Llamas Osorio Y; Department of Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland.

Ir Med J ; 115(1): 525, 2022 01 20.

Article em En | MEDLINE | ID: mdl-35279059

ABSTRACT

ABSTRACT

Presentation A 63-year-old man developed polyarthritis two months post recovery from COVID-19 infection. Diagnosis We concluded that the diagnosis was rheumatoid arthritis based upon raised inflammatory markers, positive rheumatoid factor and anti-cyclic citrullinated peptide antibodies. Treatment His symptoms improved with naproxen, corticosteroids, and methotrexate. Discussion We describe a patient with late onset rheumatoid arthritis possibly triggered or unmasked by COVID-19.

Assuntos

Artrite Reumatoide; COVID-19; Artrite Reumatoide/complicações; Artrite Reumatoide/tratamento farmacológico; Autoanticorpos; Humanos; Masculino; Pessoa de Meia-Idade; Peptídeos Cíclicos; Fator Reumatoide

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / COVID-19 Limite: Humans / Male / Middle aged Idioma: En Revista: Ir Med J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irlanda

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links